Evidence map›Paper›PMID 40504254›Full record

ArticleUrologie (Heidelberg, Germany)2026

[Management of isolated urinary bladder amyloidsis].

Agneta Seebold, Thomas Büttner, Guido Fechner, Jan-Frederic Lau, Philipp Krausewitz

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Agneta SeeboldKlinik und Poliklinik für Urologie und Kinderurologie, Uniklinik Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. Agneta.Seebold@ukbonn.de.
Thomas Büttner
Guido Fechner
Jan-Frederic Lau
Philipp Krausewitz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolated bladder amyloidosis is a rare condition characterized by amyloid deposits within the bladder wall. We present the case of a patient with recurrent, painless gross hematuria accompanied by irritative and dysuric voiding symptoms-clinical features typical of bladder amyloidosis. This case highlights the diagnostic challenges and therapeutic strategies associated with the disease, emphasizing the importance of appropriate surveillance intervals, follow-up techniques, and long-term symptom management.

Indexed as

AmyloidosisUrinary Bladder DiseasesFemaleHematuriaHumansMaleMiddle AgedUrinary BladderBladder amyloidosisDysuriaHematuriaTransurethral resection of the bladderUrothelial carcinoma

Identifiers

PMID40504254
PMCPMC12894198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.